Literature DB >> 25485593

lncRNAs: insights into their function and mechanics in underlying disorders.

Xiaolei Li1, Zhiqiang Wu1, Xiaobing Fu2, Weidong Han3.   

Abstract

Genomes of complex organisms are characterized by the pervasive expression of different types of noncoding RNAs (ncRNAs). lncRNAs constitute a large family of long—arbitrarily defined as being longer than 200 nucleotides—ncRNAs that are expressed throughout the cell and that include thousands of different species. While these new and enigmatic players in the complex transcriptional milieu are encoded by a significant proportion of the genome, their functions are mostly unknown at present. Existing examples suggest that lncRNAs have fulfilled a wide variety of regulatory roles at almost every stage of gene expression. These roles, which encompass signal, decoy, scaffold and guide capacities, derive from folded modular domains in lncRNAs. Early discoveries support a paradigm in which lncRNAs regulate transcription networks via chromatin modulation, but new functions are steadily emerging. Given the biochemical versatility of RNA, lncRNAs may be used for various tasks, including posttranscriptional processing. In addition, long intergenic ncRNAs (lincRNAs) are strongly enriched for trait-associated SNPs, which suggest a new mechanism by which intergenic trait-associated regions might function. Moreover, multiple lines of evidence increasingly link mutations and dysregulations of lncRNAs to diverse human diseases, especially disorders related to aging. In this article, we review the current state of the knowledge of the lncRNA field, discussing what is known about the genomic contexts, biological functions and mechanisms of action of these molecules. We highlight the growing evidence for the importance of lncRNAs in diverse human disorders and the indications that their dysregulations and mutations underlie some aging-related disorders. Finally, we consider the potential medical implications, and future potential in the application of lncRNAs as therapeutic targets and diagnostic markers.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disorders; Epigenetics; Gene regulation; Long noncoding RNAs (lncRNAs); Posttranscriptional; Trancriptional

Mesh:

Substances:

Year:  2014        PMID: 25485593     DOI: 10.1016/j.mrrev.2014.04.002

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  97 in total

1.  Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.

Authors:  Yang Su; Jingxiao Lu; Xianguo Chen; Chaozhao Liang; Pengcheng Luo; Cong Qin; Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-03       Impact factor: 4.553

2.  Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.

Authors:  Bo Lei; Shou-Ping Xu; Xiao-Shuan Liang; Yi-Wen Li; Jin-Feng Zhang; Guo-Qiang Zhang; Da Pang
Journal:  Tumour Biol       Date:  2015-11-10

Review 3.  The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure.

Authors:  Gwen A Lomberk; Raul Urrutia
Journal:  Surg Clin North Am       Date:  2015-07-23       Impact factor: 2.741

Review 4.  The Role of Long Noncoding RNAs in Neurodegenerative Diseases.

Authors:  Peixing Wan; Wenru Su; Yehong Zhuo
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 5.  Epigenetic modulation during hippocampal development.

Authors:  Si-Jing Fan; An-Bang Sun; Lian Liu
Journal:  Biomed Rep       Date:  2018-10-18

Review 6.  Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses.

Authors:  Nicholas W Mathy; Xian-Ming Chen
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 7.  Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.

Authors:  Frank M Davis; Katherine A Gallagher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

8.  CCDC26 knockdown enhances resistance of gastrointestinal stromal tumor cells to imatinib by interacting with c-KIT.

Authors:  Ke Cao; Minhuan Li; Ji Miao; Xiaofeng Lu; Xing Kang; Hao Zhu; Shangce Du; Xue Li; Qian Zhang; Wenxian Guan; Ying Dong; Xuefeng Xia
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

Review 9.  Long non-coding RNA: Functional agent for disease traits.

Authors:  Sriyans Jain; Nirav Thakkar; Jagamohan Chhatai; Manika Pal Bhadra; Utpal Bhadra
Journal:  RNA Biol       Date:  2016-05-26       Impact factor: 4.652

10.  Genetic suppression of cryoprotectant toxicity.

Authors:  James R Cypser; Wallace S Chick; Gregory M Fahy; Garrett J Schumacher; Thomas E Johnson
Journal:  Cryobiology       Date:  2018-11-17       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.